X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - DAILYWIRE.COM - A la Une - 07/Feb 18:26

Hims Drops Fat-Loss Pill After FDA Warning

Online telehealth company Hims & Hers on Saturday reversed course on its launch of a $49 compounded version of Novo Nordisk’s Wegovy weight-loss pill after the U.S. Food and Drug Administration said it would take action against it. “Since launching the compounded semaglutide pill on our platform, we’ve had constructive conversations with stakeholders across the ...

Articles similaires

Sorry! Image not available at this time

Hims & Hers drops plan for knockoff of Novo Nordisk’s new Wegovy weight loss pill

wn.com - 08/Feb 01:26

Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday — two days after it announced...

Sorry! Image not available at this time

Hims & Hers drops plan for knockoff of Novo Nordisk's new Wegovy weight loss pill

wn.com - 08/Feb 02:28

Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday — two days after it announced...

Sorry! Image not available at this time

Hims & Hers drops plan for knockoff of Novo Nordisk’s new Wegovy weight loss pill

ottawa.citynews.ca - 07/Feb 22:36

Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday — two days after it...

Sorry! Image not available at this time

Hims & Hers drops plan for knockoff of Novo Nordisk's new Wegovy weight loss pill

washingtontimes.com - 07/Feb 22:35

Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday - two days after it announced...

Sorry! Image not available at this time

What analysts think of Novo, Him & Hers after obesity pill withdrawal

wn.com - 09/Feb 14:38

Novo Nordisk’s Denmark-listed shares climbed more than 7%, while the stock gained close to 6% in US premarket trading after telehealth company...

Sorry! Image not available at this time

Hims GLP-1 Weight Loss: What Consumers Should Know About the Reported $49 Compounded Semaglutide Pill, Novo Nordisk Response, and Telehealth Prescription Access in 2026

mangaloremirror.com - 06/Feb 01:55

An informational overview of reported February 2026 developments, FDA-approved vs. compounded medication distinctions, Wegovy pill category context,...

Sorry! Image not available at this time

Hims GLP-1 Weight Loss: What Consumers Should Know About the Reported $49 Compounded Semaglutide Pill, Novo Nordisk Response, and Telehealth Prescription Access in 2026

mangaloremirror.com - 06/Feb 01:55

An informational overview of reported February 2026 developments, FDA-approved vs. compounded medication distinctions, Wegovy pill category context,...

Sorry! Image not available at this time

Hims & Hers launches Wegovy knockoff pill, Novo Nordisk vows to sue

washingtontimes.com - 05/Feb 21:23

Telehealth company Hims & Hers said Thursday it will launch a cheaper, off-brand version of the weight-loss pill Wegovy, just weeks after drugmaker...

Sorry! Image not available at this time

Hims & Hers launches Wegovy knockoff pill, Novo Nordisk vows to sue

washingtontimes.com - 05/Feb 21:23

Telehealth company Hims & Hers said Thursday it will launch a cheaper, off-brand version of the weight-loss pill Wegovy, just weeks after drugmaker...

Sorry! Image not available at this time

Hims & Hers drops plan for knockoff of Novo Nordisk’s new Wegovy weight loss pill

wn.com - 08/Feb 15:19

Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss...

Les derniers communiqués